illustrated that patients with detectable ctDNA, a promising prognostic biomarker, showed a trend toward higher risk for disease recurrence than those without detectable ctDNA [ 55 ].
← all excerpts
The Potential Diagnostic Value of Exosomal Long Noncoding RNAs in Solid Tumors: A Meta-Analysis and Systematic Review.
1
—
—